OncoLink Cancer Treatment and Resources

Accelerated hyperfractionated chemoradiation (C-HART) plus 5-FU/MMC is superior to HART for inoperable locally advanced head and neck cancer. Final results of the German ARO 95-06 Multicentre Trial
Presenter: V.G. BudachPresenter's Affiliation: AROType of Session: ScientificBackground The use of combined modality therapy in locally advanced head and neck cancer, specifically concurrent chemoradiation, is accepted by many clinicians...
Cetuximab monotherapy is active in patients (pts) with platinum-refractory recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN):  Results of a phase II study.
Presenter: J. TrigoPresenter's Affiliation: Vall d'Hebron University, Barcelona, SpainType of Session: ScientificBackground There is no accepted standard therapy for recurrent squamous cell carcinoma of the head and neck. Patients refractory to...
Changing patterns of practice in the management of nasopharynx carcinoma (NPC): Analysis of the National Cancer Database (NCDB)
Presenter: Langer, CoreyPresenter's Affiliation: Fox Chase Cancer CenterType of Session: ScientificBackground The standard of care in the management of nasopharynx cancer (NPC) has been defined by several randomized phase III trials using concurrent...
Phase III randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with AJCC/UICC (1997) stage 3 and 4 nasopharyngeal cancer of the endemic variety
Presenter: Joseph WeePresenter's Affiliation: National Cancer Center, SingaporeType of Session: ScientificBackground Nasopharyngeal cancer (NPC) is most prevalent in Asia and in these endemic areas, the types of NPC differ from those seen...
Phase III study of high dose radiation with or without cetuximab in the treatment of locoregionally advanced squamous cell cancer of the head and neck
Presenter: James BonnerPresenter's Affiliation: Erbitux Head and Neck Study GroupType of Session: ScientificBackground More that 500,000 people worldwide develop head and neck cancers (HNC) annually including 40,000 people in the United States with...
Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy
Presenter: J. BourhisPresenter's Affiliation: Institut Gustave-Roussy, Villejuif, FranceType of Session: ScientificBackground In 2000, the MACH-NC performed a meta-analysis including all non-metastatic head and neck studies conducted between 1965...
OncoLink I wish u knew...

Christina discusses the importance of having a social worker on your cancer care team. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS